Correction: Germany-Merck-MS drug

AP News
|
Posted: Jun 23, 2011 3:40 PM
Correction: Germany-Merck-MS drug

In a story June 22 about German drug maker Merck KGaA dropping its approval bids for multiple sclerosis drug Cladribine, The Associated Press reported erroneously the amount of a charge that Merck will take in the second quarter. The company will take a euro20 million ($28 million) charge.